The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review protocol
Date
2014
Authors
Dabrow Woods, A.
Giometti, R.
Weeks, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
The JBI Database of Systematic Reviews and Implementation Reports, 2014; 12(1):74-89
Statement of Responsibility
Anne Dabrow Woods, Renee Giometti, Susan Weeks
Conference Name
Abstract
Review question/objective - In adult intensive care unit patients experiencing alcohol withdrawal, does the use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decrease delirium severity more effectively than benzodiazepine-based therapy alone? The objective of the systematic review is to examine the best available evidence of the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone, in decreasing delirium severity associated with alcohol withdrawal in adult intensive care unit patients over the age of 18 years.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright status unknown